Thursday, March 1, 2007
|
||||
|
||||
AGENDA |
||||
08:30 |
Introduction | |||
|
Advances
in Therapy |
||||
08:35 |
Incretin Hormones: Relevance to clinical management of diabetes | Rémi Rabasa-Lhoret, MD |
||
08:55 |
Advances in Oral Therapy | Jean-Francois Yale, MD |
||
09:15 |
Importance of Reaching an LDL Goal | Morris Schweitzer, MD |
||
09:35 |
Insulin Delivery - Can we do better? | Jean-Francois Yale, MD |
||
09:55 |
Q & A and Panel Discussion | All Faculty |
||
10:25 |
BREAK | |||
State
of the Art in Diabetes Management |
||||
10:45 |
Update on Glycemic Control: Care gap | Lawrence Leiter, MD |
||
11:10 |
Can We Stop the Progression of Diabetes: DREAM | Jean-Francois Yale, MD |
||
11:35 |
ADOPT: Are all hypoglycemic agents the same? | Tina Kader, MD |
||
12:00 |
Q & A and Panel Discussion | All Faculty |
||
12:30 |
LUNCH | |||
Improving
Outcomes in Everyday Practice |
||||
13:15 |
Which patients with diabetes should have a stress test? |
David Fitchett, MD |
||
13:35 |
Oral Hypoglycemic Agents and CV risk | Tina Kader, MD |
||
13:55 |
New Initiatives From the Canadian Heart Research Centre | Anatoly Langer, MD |
||
14:15 |
Cardiovascular Risk Stratification in the Patient with Type 2 Diabetes | David Fitchett, MD |
||
14:35 |
Q & A and Panel Discussion | All Faculty |
||
15:00 |
CLOSE | |||
